Spatially Oriented Quantum Barcodes for 3D Cell Mapping

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for obtaining spatial (2D or 3D) information from tissues or cells require time-consuming microscopic examination and are limited by the number of distinguishable fluorescent labels, which is typically 3 or 4 at a time, and isotope labeling is costly.

Innovation Solution

A method for spatially labeling targets using unique nucleic acid or mass barcodes that can be assembled from subcodes, allowing for an essentially limitless number of labels, detectable by sequencing or mass-spectrometry, without the need for microscopic examination.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If fluorescent labels are used for spatial localization, then the number of distinguishable labels is limited to 3 or 4 at a time, but the method is simple and widely available

Engineering Contradiction:
Improvenumber of distinguishable labelsVSAvoidlimitation in multiplexing capability
Core Design Contradiction:
Quantity of substanceVSAdaptability or versatility

Solution Approach 1:

The labeling system is segmented into multiple independent nucleic acid barcode subcodes that can be individually synthesized and sequentially assembled on targets. Each subcode represents a distinct spatial or molecular identifier, allowing numerous labels to be combined without overlapping spectral constraints, thereby enabling high-plex spatial transcriptomics and proteomics.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent transitions from spectral dimension (fluorescent wavelengths) to sequence dimension (nucleic acid base sequences) for label differentiation. By encoding spatial and molecular information in the sequence space of DNA or RNA barcodes, the system achieves essentially limitless distinguishable labels through combinatorial sequence variation rather than relying on limited fluorophore spectra.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Quantity of substance

If iterative staining with fluorescent labels is performed to increase the number of labels, then up to 40 or 50 labels can be achieved, but the time and cost increase significantly

Engineering Contradiction:
Improvenumber of distinguishable labelsVSAvoidtime for iterative staining
Core Design Contradiction:
Quantity of substanceVSLoss of time

Solution Approach 1:

Nucleic acid barcode subcodes are pre-synthesized and prepared in advance as a library of discrete molecular components. These pre-prepared subcodes can be rapidly introduced and assembled on targets in a single or few hybridization steps, eliminating the need for repeated staining cycles and significantly reducing the time required to achieve high-plex labeling.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

Multiple barcode subcodes are merged or assembled together on the same target through sequential hybridization and ligation reactions. This combining approach allows numerous distinct labels to be accumulated on individual targets in parallel, achieving high multiplexing in a single experimental workflow rather than through sequential iterative staining.

Inventive Principle:
Principle #5Merging (Combining)

3Quantity of substance

If isotope labeling is used to achieve up to 40 labeling options, then the number of labels increases, but the cost becomes very high

Engineering Contradiction:
Improvenumber of labeling optionsVSAvoidcost of labeling
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent employs inexpensive nucleic acid barcode subcodes as disposable labeling elements. These synthetic DNA or RNA sequences can be produced at very low cost through standard oligonucleotide synthesis, replacing expensive isotopic labels while providing equivalent or superior multiplexing capability through sequence diversity.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The system changes the distinguishing parameter from isotopic mass (which requires expensive reagents and mass spectrometry detection) to nucleic acid sequence composition. By varying the base sequence of barcode subcodes, the system achieves numerous distinguishable labels that can be detected through affordable sequencing technologies rather than costly mass spectrometry.

Inventive Principle:
Principle #35Parameter changes

4Adaptability or versatility

If conventional fluorescent labeling methods are used, then the process is simple and widely available, but the number of distinguishable labels remains very limited

Engineering Contradiction:
Improvemultiplexing capabilityVSAvoidnumber of distinguishable labels
Core Design Contradiction:
Adaptability or versatilityVSQuantity of substance

Solution Approach 1:

Nucleic acid barcode subcodes serve as intermediary molecular carriers that link spatial location and molecular identity information to detectable sequencing signals. These intermediary barcodes bridge the gap between the target (protein or nucleic acid in tissue) and the detection platform (sequencing machine), enabling high-plex information encoding that far exceeds direct fluorescent labeling capability.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables high-throughput imaging of tissues or cells with an essentially limitless number of labels, allowing for qualitative and quantitative detection of DNA, RNA, and protein targets, overcoming the limitations of existing labeling methods.

Implementation Method 1

a portion of the sample is irradiated allowing the subcode to attach to only a portion of the sample

Methodology Applied
Scientific EffectPhotopolymerisation: Photopolymerisation

Data Source

PatentUS12460253B2Spatially oriented quantum barcoding of cellular targets
Publication Date: 2025.11.04 ROCHE SEQUENCING SOLUTIONS INC
  • US12460253B2 patent drawing
  • US12460253B2 patent drawing
  • US12460253B2 patent drawing

AI summary

The invention is a method of simultaneously detecting the presence and spatial location of a target in a tissue sample by attaching an anchor to the target and assembling unique positional barcodes on the anchor. The method enables analyzing cellular targets in 3D.